Now we have just passed the six-month marker (1 July) until the European Medicines Agency (EMA) moves from its current location in London to Amsterdam, as a result of Brexit, we gauge industry response to this change…
Brexit opinion
Here, we speak with Colin Newbould, director of regulatory affairs and QP services, Wasdell Group, and Thomas Beck, senior vice president, Quality Management, Recipharm, to learn their opinions on the relocation and the potential impact this and Brexit may have on both the EU and the UK.